| Amgen Switzerland AG - Pavblu 40 mg/ml, Injektionslösung |
| 69832 | | 01 | | Pavblu 40 mg/ml | | Injektionslösung | | S01LA05 | | Aflibercept | | 17.06.2025 | | |
|
| Composition |
| afliberceptum 2 mg, saccharum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 0.05 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Afliberceptum | 2mg / 0.05ml |
| | BAG: Active Agent | Dose |
|---|
| Afliberceptum | 2 mg |
| | | | Inactive agents |
|---|
| Polysorbatum 80 | | Saccharum | | Trehalosum Dihydricum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 549.84 | 614.40 | B | SL | No |
|
